在患者衍生瘤器官构造之前和之后,化疗药物敏感性的差异
Fang Shao1, Xin Huang2, Zhihong Ma3
1Laboratory of Oncology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, China; Largescale Equipment Platform, Changzhou Medical Center, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, China.
Toxicology and applied pharmacology
|April 14, 2025
概括
患者衍生器官 (PDO) 为癌症研究提供了一个有前途的模型. 这项研究优化了PDO用于胃癌和结肠癌,与新鲜瘤细胞相比显示出更强的药物敏感性.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 3D 细胞培养 3D 细胞培养
背景情况:
- 患者衍生器官 (PDO) 正在成为各种癌症类型的有价值的临床前模型.
- 这项研究的重点是优化3D有机体模型的构建,以实现个性化胃癌和结肠癌治疗.
研究的目的:
- 从胃和结肠瘤中优化患者衍生器官 (PDO) 的生成.
- 与新分离的瘤细胞相比,评估PDO的药物敏感性.
- 促进针对胃肠道癌症的个性化治疗策略的开发.
主要方法:
- 瘤组织被解离为单细胞悬浮液或培养为有机体.
- 对瘤细胞和有机体进行了RNA测序 (RNA-seq).
- 细胞毒性和扩散试验使用牛津,格姆西塔,5-甲和帕克利塔克塞尔进行.
主要成果:
- 从手术和活检样本中成功确定有机体.
- 有机体保持了原始瘤的组织学特征和基因表达特征,通过通道保持稳定的形态.
- 与新鲜瘤细胞相比,胃癌和结肠癌PDO对帕克利塔塞尔和5-甲的敏感性增加;培养后干性基因表达减少.
结论:
- 与新鲜分离的瘤细胞相比,优化的PDO模型显示出强大的生长和增强的药物敏感性.
- 这些发现突出了PDO在个性化癌症治疗研究中的潜力.
- 由于观察到的差异,建议在解释基于有机体的测定中的药物敏感性结果时谨慎行事.
相关概念视频
Cell-mediated Immune Responses
Overview
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
Tissue-Drug Binding: Localization of Drugs and its Significance
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...


